CURRICULUM VITAE
NAME & SURNAME: Mehmet Kanbay
BIRTH PLACE: Tokat
NATIONALITY: Turkish
MARITAL STATUS: Married
FOREIGN LANGUAGE: English
Present Title : Associate Professor, MD, FERA,
Department of Medicine, Division of Nephrology, Koç University School of Medicine, Istanbul, Turkey
E-mail : drkanbay@yahoo.com
mkanbay@ku.edu.tr
EDUCATION TRAINING EMPLOYMENT
1993-2000 Istanbul University, Cerrahpasa School of Medicine (in English), Istanbul
2000-2005 Residency, Department of Internal Medicine, Baskent University School of Medicine, Ankara 2005-2007
2007-2008
2009-2010
Residency, Section of Nephrology,
Fatih University School of Medicine, Ankara
Clinical Fellowship (International Society of Nephrology (ISN)), Yale University School of Medicine in Section of Nephrology, Connecticut, USA
Turkish Mandatory Military Service, Gulhane Military Medical School, Department of Medicine, Division of Nephrology, Ankara, Turkey
2010-2012
2012-2014
Chair of Internal Medicine and Nephrology, Associate Professor in Section of Nephrology and Hypertension,
Kayseri Training and Research Hospital, Kayseri, Turkey
Associate Professor in Section of Nephrology and Hypertension, Medeniyet University School of Medicine, Istanbul, Turkey
2014- Associate Professor in Section of Nephrology,
Koç University School of Medicine, Istanbul, Turkey
RESEARCH INTEREST
1. Bone-Mineral Disorders in Chronic Kidney Disease 2. Cardiovascular Disease in Chronic Kidney Disease
3. Uric acid in Chronic Kidney Disease and Cardiovascular Disease 4. Anemia in Chronic Kidney Disease
5. Hypertension
6. Inflammation in Chronic Kidney Disease
ACADEMIC ACTIVITIES:
EURECA-m (EUropean REnal and CArdiovascular Medicine) is an ERA-EDTA (European Renal Association) WORKING GROUP BOARD MEMBER.
Link: http://www.era-edta.org/eureca-m/eureca-m_members.htm
STATISTIC PROGRAM
1. Advanced user of SPSS program (I have also course certificate from Yale University School of Medicine)
MEMBERSHIPS:
1. European Renal Association- European Dialysis and Transplantation Association
2. International Society of Nephrology 3. American Society of Nephrology
4. European Cardio-Renal Medicine Working group member 5. Turkish Society of Nephrology
INVITED JOURNAL EDITOR:
1. Seminars in Nephrology, Uric acid issue, 2011 Sep;31(5):391-3.
JOURNAL EDITORIAL BOARD MEMBER:
1. International journal of urology and nephrology 2. Nephrology reviews
3. Journal of Geriatric Cardiology 4. World Journal of Nephrology
REVIEWER for SCI SCIE JOURNALS:
1. Clinical journal of American society of nephrology 2. Nephrology dialysis and transplantation
3. American Journal of Kidney Disease 4. Nephrology Dialysis and Transplantation 5. PLOS ONE
6. American Journal of Hypertension 7. Clinical and Experimental Hypertension 8. Renal Failure
9. Nephron Clinical Practice 10. Blood Purification
11. Kidney Blood Pressure and Research 12. Renal Failure
INVITED SPEAKER IN INTERNATIONAL AND NATIONAL CONGRESS:
I gave many lectures in international (including ERA-EDTA congresses and CME meetings) and national nephrology congresses.
PUBLICATIONS: 152
H-index: 22 (Web of Science), 29 (Google Scholar)
TOTAL NUMBER OF CITATIONS: 1669 (Web of Science), 2637 (Google Scholar) INTERNATIONAL BOOK EDITOR:
1. Adrian Covic, Mehmet Kanbay, Edgar Lerma. Dyslipidemia in Kidney Disease, First Edition, Springer, 2014
INTERNATIONAL BOOK CHAPTERS:
1. Uric acid and Kidney Disease Chapter: Diseases of the Kidney and Urinary Tract, 9.th Edition, 2012.
Selected Special Awards:
- Fellow of the European Renal Association (FERA),
ERA-EDTA Distinguished Fellow, 2014
- 2014 Winner of Young Scientist Award of TUBITAK
- International Society of Nephrology Fellowship Scholar,
PEER-REVIEWED PUBLICATIONS INDEXED IN SCI SCIE JOURNALS
1. Nistor I, Bararu I, Apavaloaie MC, Voroneanu L, Donciu MD, Kanbay M, Nagler EV, Covic A. Vasopressin receptor antagonists for the treatment of heart failure: a systematic review and meta-analysis of randomized controlled trials. Int Urol Nephrol. 2014 Oct 4. [Epub ahead of print] PMID:25281314 [PubMed - as supplied by publisher]
2. Schiller A, Apetrii M, Onofriescu M, Siriopol D, Veisa G, Schiller O, Bob F, Timar R, Mihaescu A, Kanbay M, Covic A. Prognostic significance of 25-hydroxivitamin D entirely explained by a higher comorbidity burden: Experience from a South-Eastern European Dialysis Cohort. Hemodial Int. 2014 Sep 23. doi: 10.1111/hdi.12226. [Epub ahead of print]
3. Solak Y, Covic A, Kanbay M. What Do We Know and Do Not Know About Vitamin D?: A Causal Association Between Vitamin D Receptor Genetic Polymorphism and Hypertension. J Clin Hypertens
(Greenwich). 2014 Sep;16(9):627-8. doi: 10.1111/jch.12383. 4. Kanbay M, Siriopol D, Saglam M, Gulcan Kurt Y, Gok M,
Cetinkaya H, Karaman M,Umut Unal H, Oguz Y, Sari S, Eyileten T, Goldsmith D, Vural A, Veisa G, Covic A, Ilker Yilmaz M. Serum
sclerostin and adverse outcomes in non-dialyzed chronic kidney disease patients. J Clin Endocrinol Metab. 2014 Oct;99(10):E1854-61.
5. Aribas A, Kayrak M, Ulucan S, Keser A, Demir K, Alibasic H, Akilli H, Solak Y, Avci A, Turan Y, Kaya Z, Katlandur H, Kanbay M. The relationship between uric acid and erectile dysfunction in hypertensive subjects. Blood Press. 2014 Jul 6:1-7.
6. Yilmaz MI, Siriopol D, Saglam M, Kurt YG, Unal HU, Eyileten T, Gok M, Cetinkaya H, Oguz Y, Sari S, Vural A, Mititiuc I, Covic A,
Kanbay M. Plasma endocan levels associate with inflammation,
vascular abnormalities,cardiovascular events, and survival in chronic kidney disease. Kidney Int. 2014 Jul 2. doi: 10.1038/ki.2014.227. 7. Turak O, Afsar B, Ozcan F, Canpolat U, Grbovic E, Mendi MA,
Oksuz F, Siriopol D, Covic A, Caliskan M, McFann K, Johnson RJ,
surge, uric Acid, and cardiovascular outcomes in hypertensive patients. J Clin Hypertens (Greenwich). 2014 Jul;16(7):530-5.
doi:10.1111/jch.12359.
8. Kanbay M, Solak Y, Gaipov A, Takir M, Weiner DE. Allopurinol as a kidney-protective, cardioprotective, and antihypertensive agent: hype or reality? Blood Purif. 2014;37(3):172-8. doi: 10.1159/000360520. Epub 2014 May 27.
9. Afsar B, Covic A, Kanbay M. Renal artery stenting in patients with uncontrolled hypertension: should we? And to whom? J Clin Hypertens (Greenwich). 2014 Jul;16(7):479-81. doi:10.1111/jch.12344.
10. Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, Mallamaci F,Massy ZA, Rossignol P, Vanholder R, Wiecek A, Zoccali C, London GM; Board of the EURECA-m Working Group of ERA-EDTA. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014 May 24;383(9931):1831-43. doi: 10.1016/S0140-6736(14)60384-6.
11. Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, Karaman M, Oguz Y, Eyileten T, Vural A, Covic A, Goldsmith D, Turak O, Yilmaz MI. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014 Aug;46(8):1619-25. doi:10.1007/s11255-014-0730-1.
12. Kanbay A, Inonu H, Solak Y, Erden A, Uslu E, Yuksel SA, Ozturk MA, McFann K, Johnson RJ, Kanbay M. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome. Eur J Intern Med. 2014 Jun;25(5):471-6. doi:
10.1016/j.ejim.2014.04.005.
13. Yilmaz MI, Solak Y, Saglam M, Cayci T, Acikel C, Unal HU, Eyileten T, Oguz Y, Sari S, Carrero JJ, Stenvinkel P, Covic A, Kanbay M. The Relationship between IL-10 Levels and Cardiovascular Events in
Patients with CKD. Clin J Am Soc Nephrol. 2014 Jul 7;9(7):1207-16. doi: 10.2215/CJN.0866081.
14. Teke HÜ, Başak M, Teke D, Kanbay M. Serum Level of Lactate Dehydrogenase is a Useful Clinical Marker to Monitor Progressive
Multiple Myeloma Diseases: A Case Report. Turk J Haematol. 2014 Mar;31(1):84-7. doi: 10.4274/Tjh.2013.0044. Epub 2014 Mar 5. 15. Kanbay M, Siriopol D, Nistor I, Elcioglu OC, Telci O, Takir M,
Johnson RJ, Covic A. Effects of allopurinol on endothelial dysfunction: a meta-analysis. Am J Nephrol. 2014;39(4):348-56. doi:
10.1159/000360609.
16. Afsar B, Turkmen K, Covic A, Kanbay M. An update on coronary artery disease and chronic kidney disease. Int J Nephrol.
2014;2014:767424. doi:10.1155/2014/767424.
17. Onofriescu M, Hogas S, Voroneanu L, Apetrii M, Nistor I, Kanbay
M, Covic AC. Bioimpedance-guided fluid management in maintenance
hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis. 2014 Jul;64(1):111-8. doi: 10.1053/j.ajkd.2014.01.420.
18. Solak Y, Akilli H, Kayrak M, Aribas A, Gaipov A, Turk S, Perez-Pozo SE, Covic A, McFann K, Johnson RJ, Kanbay M. Uric acid level and erectile dysfunction in patients with coronary artery disease. J Sex Med. 2014 Jan;11(1):165-72. doi: 10.1111/jsm.12332.
19. Ozkok A, Kanbay A, Odabas AR, Covic A, Kanbay M. Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor. Clin Exp Hypertens. 2014;36(4):211-6. doi:
10.3109/10641963.2013.804546.
20. Akin F, Ayça B, Köse N, Celik O, Yilmaz Y, Akin MN, Arinc H, Ozkok A, Covic A, Kanbay M. Serum vitamin D and C-reactive protein levels are independently associated with diastolic dysfunction. J Investig Med. 2014 Jan;62(1):43-8.
21. Solak Y, Yilmaz MI, Saglam M, Demirbas S, Verim S, Unal HU, Gaipov A, Oguz Y, Kayrak M, Caglar K, Vural A, Turk S, Covic A,
Kanbay M. Mean Corpuscular Volume is Associated with Endothelial
Dysfunction and Predicts Composite Cardiovascular Events in Patients with Chronic Kidney Disease. Nephrology (Carlton). 2013 Jul 12. doi: 10.1111/nep.12130.
22. Kanbay M, Bayram Y, Solak Y, Sanders PW. Dietary potassium: a key mediator of the cardiovascular response to dietary sodium chloride. J Am Soc Hypertens. 2013 Sep-Oct;7(5):395-400.Kanbay M, Turak O,
Johnson RJ. REPLY TO: Serum uric acid still carries controversies about its role in endothelial dysfunction. J Clin Hypertens (Greenwich). 2013 Apr;15(4):297.
23. Sen N, Afsar B, Ozcan F, Buyukkaya E, Isleyen A, Akcay AB, Yuzgecer H, Kurt M, Karakas MF, Basar N, Hajro E, Kanbay M. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Atherosclerosis. 2013 May;228(1):203-10.
24. Johnson RJ, Sánchez-Lozada LG, Mazzali M, Feig DI, Kanbay M, Sautin YY. What are the key arguments against uric acid as a true risk factor for hypertension? Hypertension. 2013 May;61(5):948-51.
25. Yilmaz MI, Turgut F, Kanbay M, Saglam M, Sonmez A, Yaman H, Demirbas S, Unal HU, Gok M, Karaman M, Ay SA, Demirkaya E, Covic A, Carrero JJ. Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. Int Urol Nephrol. 2013 Aug;45(4):1071-8.
26. Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B,
Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart Jun;99(11):759-66.
27. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, Ishimoto T, Li N, Marek G, Duranay M, Schreiner G, Rodriguez-Iturbe B, Nakagawa T, Kang DH, Sautin DY, Johnson RJ. Uric acid induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress: Potential Role in Fructose-Dependent
and-Independent Fatty Liver. J Biol Chem. 2012 Nov 23;287(48):40732-44. 28. KanbayM, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E,
Unal HU, Arslan E, Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ. Serum Uric Acid Independently Predicts Cardiovascular Events in Advanced Nephropathy. Am J Nephrol 2012;36:324-331. 29. Turak O, Özcan F, Tok D, İşleyen A, Sökmen E, Taşoğlu I,
Aydoğdu S, Sen N, McFann K, Johnson RJ, Kanbay M. Serum Uric Acid, Inflammation and Nondipping Circadian Pattern in Essential Hypertension. Journal of Clinical Hypertension (In press).
30. Turkmen K, Tonbul HZ, Erdur FM, Guney I, Kayikcioglu H, Altintepe L, Ozbek O,Yilmaz MI, Gaipov A, Turk S, Covic A, Kanbay M. Peri-aortic fat tissue and malnutrition-inflammation
atherosclerosis/calcification syndrome in end-stage renal disease patients. Int Urol Nephrol. 2012 Sep 23. [Epub ahead of print]
31. Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU,
Gok M, Caglar K,Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A. Relationship between Serum Magnesium Levels and Cardiovascular Events in Chronic Kidney Disease Patients. Am J Nephrol. 2012 Aug 30;36(3):228-237.
32. Solak Y, Biyik Z, Atalay H, Gaipov A, Guney F, Turk S, Covic A, Goldsmith D, Kanbay M. Pregabalin versus Gabapentin in the Treatment of Neuropathic Pruritus in Maintenance Hemodialysis Patients: a Prospective Crossover Study. Nephrology (Carlton). 2012 Aug 22. doi: 10.1111/j.1440-1797.2012.01655.
33. Ozkok A, Elcioglu OC, Cukadar T, Bakan A, Sasak G, Atilgan KG, Alisir S, Kanbay M, Covic A, Odabas AR. Low serum pancreatic enzyme levels predict mortality and are associated with malnutrition-inflammation-atherosclerosis syndrome in patients with chronic kidney disease. Int Urol Nephrol. 2012 Aug 2.[Epub ahead of print]
34. Solak Y, Gul EE, Kayrak M, Atalay H, Abdulhalikov T, Turk S, Covic A, Kanbay M. Electrocardiographic P-wave characteristics in patients with end-stage renal disease: P-index and interatrial block. Int Urol Nephrol. 2012 May 12. [Epub ahead of prin
35. Akin F, Ayça B, Köse N, Duran M, Sari M, Uysal OK, Karakukcu C, Arinc H, Covic A, Goldsmith D, Okçün B, Kanbay M. Serum vitamin D levels are independently associated with severity of coronary artery disease. J Investig Med. 2012 Aug;60(6):869-73.
36. Kanbay M, Yilmaz MI, Afsar B, Saglam M, Akgul EO, Cayci T,
Caglar K, Unal HU, Gok M, Vural A, Covic A. Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor? Int Urol Nephrol. 2012 Mar 23. [Epub ahead of print]
37. Cakar M, Kanbay M, Sarlak H, Akhan M, Gok M, Unal HU, Demirbas S, Yilmaz MI.Findings of biopsy-proven chronicity and
end-stage renal failure associated with oral sodium phosphate solution. Ren Fail. 2012;34(4):499-501.
38. Akcay AB, Ozlu MF, Sen N, Cay S, Ozturk OH, Yalcn F, Bilen P, Kanat S, Karakas MF, Isleyen A, Demir AD, Sogut S, Covic A, Kanbay
M. Prognostic significance of neutrophil gelatinase-associated lipocalin
in ST-segment elevation myocardial infarction. J Investig Med. 2012 Feb;60(2):508-13.
39. Afsar B, Elsurer R, Covic A, Kanbay M. Vascular access type, health-related quality of life, and depression in hemodialysis patients: a preliminary report. J Vasc Access. 2012 Apr-Jun;13(2):215-20.
40. Kanbay M, Wolf M, Selcoki Y, Solak Y, Ikizek M, Uysal S, Segall L,
Armutcu F, Eryonucu B, Duranay M, Goldsmith D, Covic A. Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease.Int Urol Nephrol. 2012 Aug;44(4):1169-75.
41. Ozturk MA, Kanbay M, Kasapoglu B, Onat AM, Guz G, Furst DE, Ben-Chetrit E. Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S77-86. Epub 2011 Sep 27. Review.
42. Johnson RJ, Kanbay M, Sánchez-Lozada LG. The rediscovery of uric acid in cardiorenal disease: introduction. Semin Nephrol. 2011 Sep;31(5):391-3.
43. Afsar B, Elsurer R, Kanbay M. The relationship between breakfast, lunch and dinner eating pattern and hemodialysis sessions, quality of life, depression and appetite in hemodialysis patients. Int Urol Nephrol. 2012 Oct;44(5):1507-14.
44. Johnson RJ, Kanbay M, Kang DH, Sánchez-Lozada LG, Feig D. Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension. Hypertension. 2011 Oct;58(4):548-9. 45. Yilmaz MI, Solak Y, Covic A, Goldsmith D, Kanbay M. Renal
anemia of inflammation: the name is self-explanatory. Blood Purif. 2011;32(3):220-5.
46. Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I,
endothelial function and estimated glomular filtration rate in
asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011 Aug;6(8):1887-94.
47. Kanbay M, Turkmen K, Ecder T, Covic A. Ambulatory blood
pressure monitoring: from old concepts to novel insights. Int Urol Nephrol. 2012 Feb;44(1):173-82.
48. Sen N, Ozlu MF, Akgul EO, Kanat S, Cayci T, Turak O, Yaman H, Sokmen E, Ozcan F, Maden O, Demir AD, Covic A, Kanbay M.
Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion. Atherosclerosis. 2011 Nov;219(1):304-10.
49. Kanbay M, Solak Y, Covic A, Goldsmith D. Sudden cardiac death in
patients with chronic kidney disease: prevention is the sine qua non. Kidney Blood Pres Res. 2011;34(4):269-76.
50. Afsar B, Elsurer R, Covic A, Johnson RJ, Kanbay M. Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol. 2011;34(1):49-54.
51. Kanbay M, Afsar B, Covic A. Uric acid as a cardiometabolic risk
factor: to be or not to be. Contrib Nephrol. 2011;171:62-7.
52. Karadag R, Keskin UC, Koktener A, Selcoki Y, Hepsen IF, Kanbay
M. Ocular pulse amplitude and retrobulbar blood flow change in dipper
and non-dipper individuals. Eye (Lond). 2011 Jun;25(6):762-6.
53. Basar N, Sen N, Ozcan F, Erden G, Kanat S, Sokmen E, Isleyen A, Yuzgecer H, Ozlu MF, Yildirimkaya M, Maden O, Covic A, Johnson RJ,
Kanbay M. Elevated serum uric acid predicts angiographic impaired
reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. J Investig Med. 2011 Aug;59(6):931-7.
54. Kanbay M, Ikizek M, Solak Y, Selcoki Y, Uysal S, Armutcu F,
Eryonucu B, Covic A, Johnson RJ. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol. 2011;33(4):325-31. 55. Kanbay M, Yilmaz MI, Sonmez A, Turgut F, Saglam M, Cakir E,
endothelial dysfunction in patients with nondiabetic chronic kidney disease. Am J Nephrol. 2011;33(4):298-304.
56. Basar N, Sen N, Kanat S, Ozlu MF, Ozcan F, Cay S, Erden G, Cagli KE, Yildirimkaya M, Maden O, Covic A, Kanbay M. Lower fetuin-A predicts angiographic impaired reperfusion and mortality in ST-elevation myocardial infarction. J Investig Med. 2011 Jun;59(5):816-22.
57. Kanbay M, Chen Y, Solak Y, Sanders PW. Mechanisms and
consequences of salt sensitivity and dietary salt intake. Curr Opin Nephrol Hypertens. 2011 Jan;20(1):37-43.
58. Kanbay M, Solak Y, Dogan E, Lanaspa MA, Covic A. Uric acid in
hypertension and renal disease: the chicken or the egg? Blood Purif. 2010;30(4):288-95.
59. Duranay M, Segall L, Sen N, Yilmaz FM, Cetin M, Isleyen A,
Kanbay M, Covic A. Bone morphogenic protein-7 serum level
decreases significantly in patients with contrast-induced nephropathy. Int Urol Nephrol. 2011 Sep;43(3):807-12.
60. Kanbay M, Sánchez-Lozada LG, Franco M, Madero M, Solak Y,
Rodriguez-Iturbe B, Covic A, Johnson RJ. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant. 2011 Feb;26(2):430-7. 61. Kanbay M, Afsar B, Goldsmith D, Covic A. Sudden death in
hemodialysis: an update. Blood Purif. 2010;30(2):135-45.
62. Kanbay M, Nicoleta M, Selcoki Y, Ikizek M, Aydin M, Eryonucu B,
Duranay M, Akcay A, Armutcu F, Covic A. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol. 2010 Oct;5(10):1780-6.
63. Kargili A, Turgut FH, Karakurt F, Kasapoglu B, Kanbay M, Akcay A. A forgotten but important risk factor for severe hyponatremia:
myxedema coma. Clinics (Sao Paulo). 2010 Apr;65(4):447-8.
64. Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL, Goldsmith DJ. Vascular calcification in chronic kidney disease. Clin Sci (Lond). 2010 Apr 28;119(3):111-21.
65. Mazzali M, Kanbay M, Segal MS, Shafiu M, Jalal D, Feig DI, Johnson RJ. Uric acid and hypertension: cause or effect? Curr Rheumatol Rep. 2010 Apr;12(2):108-17.
66. Bavbek N, Akay H, Uz B, Uz E, Turgut F, Kanbay M, Senes M, Akcay A, Duranay M. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients. Ren Fail. 2010
Jan;32(2):157-61.
67. Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A. Magnesium
in chronic kidney disease: challenges and opportunities. Blood Purif. 2010;29(3):280-92.
68. Türkay C, Aydoğan T, Karanfil A, Uyar ME, Selçoki Y, Kanbay M. T-wave depletion and bradycardia possibly secondary to acute
pancreatitis: review of the literature. Turk J Gastroenterol. 2009 Dec;20(4):295-7.
69. Duranay M, Kanbay M, Akay H, Unverdi S, Sürer H, Altay M,
Kirbaş I, Covic A,Zoccali C. Nebivolol improves renal function in patients who underwent angioplasty due to renal artery stenosis: a pilot study. Nephron Clin Pract. 2010;114(3):c213-7.
70. Kanbay M, Afsar B, Gusbeth-Tatomir P, Covic A. Arterial stiffness
in dialysis patients: where are we now? Int Urol Nephrol. 2010 Sep;42(3):741-52.
71. Kanbay M, Kasapoglu B, Perazella MA. Acute tubular necrosis and
pre-renal acute kidney injury: utility of urine microscopy in their
evaluation- a systematic review. Int Urol Nephrol. 2010 Jun;42(2):425-33.
72. Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A.
Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management. Blood Purif. 2010;29(1):1-12. 73. Kanbay M, Turgut F, Covic A, Goldsmith D. Statin treatment for
dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence. J Nephrol. 2009 Sep-Oct;22(5):598-609. 74. Turgut F, Kasapoğlu B, Kanbay M. Uric acid, cardiovascular
mortality, and long-term outcomes in CKD. Am J Kidney Dis. 2009 Sep;54(3):582; author reply
75. Kanbay M, Covic A, Coca SG, Turgut F, Akcay A, Parikh CR.
Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol.
2009;41(3):617-27.
76. Guz G, Kanbay M, Ozturk MA. Current perspectives on familial Mediterranean fever. Curr Opin Infect Dis. 2009 Jun;22(3):309-15. 77. Kanbay M, Goldsmith D, Akcay A, Covic A. Phosphate - the silent
stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif. 2009;27(2):220-30.
78. Kanbay M, Kasapoglu B, Akcay A. Sodium bicarbonate vs sodium
chloride in preventing contrast medium-induced nephropathy. JAMA. 2009 Jan 28;301(4):378;author reply
79. Bavbek N, Isik B, Kargili A, Uz E, Uz B, Kanbay M, Turgut F, Karakurt F, Akcay A. Association of obesity with inflammation in occult chronic kidney disease. J Nephrol. 2008 Sep-Oct;21(5):761-7.
80. Kurtaran H, Uyar ME, Kasapoglu B, Turkay C, Yilmaz T, Akcay A,
Kanbay M. Role of Helicobacter pylori in pathogenesis of upper
respiratory system diseases. J Natl Med Assoc. 2008 Oct;100(10):1224-30.
81. Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD. Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant. 2008 Nov;8(11):2378-90. Review. Erratum in: Am J Transplant. 2009 Apr;9(4):865.Kambay, M [corrected to Kanbay, M]. 82. Kanbay M, Turgut F, Uyar ME, Akcay A, Covic A. Causes and
mechanisms of nondipping hypertension. Clin Exp Hypertens. 2008 Oct;30(7):585-97.
83. Kanbay M, Kasapoglu B, Turgut F, Akcay A. Secondary
hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int. 2008
Oct;74(7):967-8; author reply 968.
84. Perazella MA, Coca SG, Kanbay M, Brewster UC, Parikh CR. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol. 2008 Nov;3(6):1615-9.
85. Selcuk H, Korkmaz M, Kanbay M, Tore E, Sumer H, Unal H, Yeloglu O, Gur G, Bilezikci B, Demirhan B, Yilmaz U, Boyacioglu S. Total colonic polyp diameter: a marker for the risk of malignancy? Hepatogastroenterology. 2008 May-Jun;55(84):936-9.
86. Karadag R, Yagci R, Aydin B, Kanbay M, Erdurmus M, Keskin UC, Akcay A, Durmus M. Effects of erytropoietin treatment and hemodialysis on the serum endothelin level and intraocular pressure of hemodialysis patients. Int Ophthalmol. 2009 Oct;29(5):385-8.
87. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol.
2008;40(4):1075-82.
88. Schmitt R, Coca S, Kanbay M, Tinetti ME, Cantley LG, Parikh CR. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis. 2008
Aug;52(2):262-71.
89. Uz E, Bayrak O, Uz E, Kaya A, Bayrak R, Uz B, Turgut FH, Bavbek N, Kanbay M, Akcay A. Nigella sativa oil for prevention of chronic cyclosporine nephrotoxicity: an experimental model. Am J Nephrol. 2008;28(3):517-22.
90. Selcoki Y, Gorpelioglu C, Turgut F, Sarifakioglu E, Ozkara A, Tekin O, Kanbay M, Akcay A. Isotretinoin: is there any arrhythmic effect? Int J Dermatol. 2008 Feb;47(2):195-7.
91. Altay M, Turgut F, Akay H, Kanbay M, Babali A, Akcay A, Duranay M, Yigitoglu R, Covic A. Dyspepsia in Turkish patients on continuous ambulatory peritoneal dialysis. Int Urol Nephrol. 2008;40(1):211-7. 92. Ozkara A, Turgut F, Selcoki Y, Karanfil A, Metin MR, Kanbay M,
Tekin O, Akcay A. Probrain natriuretic peptide for assessment of efficacy in heart failure treatment. Adv Ther. 2007 Nov-Dec;24(6):1233-9.
93. Kanbay M, Turgut F, Karakurt F, Isik B, Alkan R, Akcay A, Yigitoglu
R, Covic A. Relation between serum thyroid hormone and 'nondipper' circadian blood pressure variability. Kidney Blood Press Res.
94. Uz E, Bavbek N, Turgut FH, Kanbay M, Kaya A, Akcay A.
Cefuroxime-induced lupus. J Natl Med Assoc. 2007 Sep;99(9):1066-7. 95. Turgut F, Bayrak O, Kanbay M, Ozkara A, Uz E, Bavbek N, Kargili
A, Akcay A. Circadian rhythm of blood pressure in patients with benign prostatic hyperplasia. Scand J Urol Nephrol. 2008;42(1):47-52.
96. Türkay C, Yönem O, Arici S, Koyuncu A, Kanbay M. Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis. Dig Dis Sci. 2008 Mar;53(3):789-93.
97. Kanbay M, Isik B, Akcay A, Ozkara A, Karakurt F, Turgut F, Alkan
R, Uz E,Bavbek N, Yigitoglu R, Covic A. Relation between serum calcium, phosphate,parathyroid hormone and 'nondipper' circadian blood pressure variability profile in patients with normal renal function. Am J Nephrol. 2007;27(5):516-21.
98. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E,
Akcay A, Yigitoglu R, Covic A. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007;39(4):1227-33.
99. Turgut F, Kanbay M, Kaya A, Uz B, Akcay A. Bilateral renal artery embolization in a case with severe proteinuria secondary to amyloidosis in a hemodialysis patient. Amyloid. 2007 Jun;14(2):157-8.
100. Kanbay M, Akcay A, Delibasi T, Uz B, Kaya A, Koca C, Turgut F,
Bavbek N, Uz E, Duranay M, Yigitoglu R. Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure. Adv Ther. 2007 Mar-Apr;24(2):346-52.
101. Yanik B, Bavbek N, Yanik T, Inegöl I, Kanbay M, Turgut FH, Uz E, Akçay A. The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women. Ren Fail. 2007;29(4):471-6.
102. Kanbay M, Bavbek N, Delibasi T, Koca C, Kaya A, Altay M, Akcay
A, Duranay M, Yigitoglu R. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease. Ren Fail. 2007;29(3):309-13.
103. Turgut F, Kanbay M, Isik B, Akcay A. Risk factors affecting the incidence of chronic kidney disease. Kidney Int. 2007 May;71(10):1076; authoe reply 1076.
104. Aytac S, Türkay C, Kanbay M. Helicobacter pylori stool antigen assay in hyperemesis gravidarum: a risk factor for hyperemesis gravidarum or not? Dig Dis Sci. 2007 Oct;52(10):2840-3.
105. Duranay M, Kanbay M, Turgut F, Altay M, Akcay A. Comparison of incidence of peritonitis between peritoneal dialysis solution types. Nephron Clin Pract. 2007;106(1):c57-60.
106. Selcuk H, Uruc I, Temel MA, Ocal S, Huddam B, Korkmaz M, Unal H, Kanbay M, Savas N, Gur G, Yilmaz U, Haberal M. Factors
prognostic of survival in patients awaiting liver transplantation for end-stage liver disease. Dig Dis Sci. 2007 Nov;52(11):3217-23.
107. Kanbay M, Kasapoglu B, Akcay A. An occult risk factor for
proteinuria: Helicobacter pylori infection. Med Hypotheses. 2007;69(3):709-10.
108. Kanbay M, Kasapoglu B, Isik B, Turgut F, Uz E, Bavbek N, Akcay
A. H. pylori: a major risk factor for 'non-dipper' circadian variability profile in blood pressure? Med Hypotheses. 2007;69(2):463-4.
109. Turgut F, Kanbay M, Uz B, Carlioglu A, Selcoki Y, Karanfil A, Alici O, Akcay A. A forgotten but important risk factor for infective
endocarditis in patients with prosthetic valve: pedicure. Scand J Infect Dis. 2007;39(3):274-6.
110. Kanbay M, Alkis M, Turgut F, Uz E, Bavbek N, Akcay A.
Hyponatremia due to an additive effect of carbamazepine and clarithromycin. South Med J. 2007 Feb;100(2):222.
111. Kanbay M, Kasapoglu B, Turgut F, Uz E, Bavbek N, Akcay A.
Helicobacter pylori: a major risk factor for endothelial dysfunction? Med Hypotheses. 2007;69(1):227-8.
112. Kanbay M, Selcuk H, Yilmaz U, Boyacioglu S. Recurrent acute
pancreatitis probably secondary to lisinopril. South Med J. 2006 Dec;99(12):1388-9.
113. Selcuk H, Kanbay M, Korkmaz M, Gulsener P, Gur G, Yilmaz U, Boyacioglu S. Route of nutrition has no effect on the development of infectious complications. J Natl Med Assoc. 2006 Dec;98(12):1963-6. 114. Altay M, Kanbay M, Kurultak I, Altay FA, Aydogan T, Akcay A,
Duranay M. A case of bilateral psoas abscesses and lumbar
osteomyelitis due to recurrent salmonella infection. J Natl Med Assoc. 2006 Nov;98(11):1855-6.
115. Kaya A, Kanbay M, Bayrak O, Eken G, Memis L, Akcay A, Duranay M. Primary renal lymphoma associated with hepatitis C virus infection. Leuk Lymphoma. 2006 Sep;47(9):1976-8.
116. Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A,
Duranay M,Yigitoglu R. Effect of dialysis type on serum lipids, polipoproteins, and lipoproteins. Ren Fail. 2006;28(7):567-71.
117. Usta B, Gozdemir M, Turgut F, Sert H, Kanbay M, Demircioglu RI, Akcay A. Does hypocalcemia trigger pulmonary embolism? Med
Hypotheses. 2007;68(2):464-5.
118. Sahin M, Tutuncu NB, Kanbay M, Guvener ND. Surgery for
hyperthyroidism in Down syndrome: case report. Mt Sinai J Med. 2006 Sep;73(5):784-6.
119. Kanbay M, Gur G, Akcay A, Selcuk H, Yilmaz U, Arslan H,
Boyacioglu S, Ozdemir FN. Is hepatitis C virus positivity a contributing factor to occult hepatitis B virus infection in hemodialysis patients? Dig Dis Sci. 2006 Nov;51(11):1962-6.
120. Aydogan T, Kanbay M, Alici O, Kosar A. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets. 2006
Aug;17(5):328-31.
121. Kanbay M, Selcuk H, Gur G, Yilmaz U, Boyacioglu S. Involvement
of the esophagus in a patient with pemphigus vulgaris who was on immunosuppressive therapy. J Natl Med Assoc. 2006 Aug;98(8):1369-70.
122. Guler ZM, Kanbay A, Kanbay M, Ciftci B, Erdogan Y. Tuberculous epididymitis presenting with Addison's disease: a rare case. J Natl Med Assoc. 2006 Jul;98(7):1175-6.
123. Kanbay M, Altundag K, Gur G, Boyacioglu S. Non-Hodgkin's
lymphoma presenting with granulomatous hepatitis and hemophagocytosis. Leuk Lymphoma. 2006 Apr;47(4):767-9
124. Selcuk H, Kanbay M, Korkmaz M, Gur G, Akcay A, Arslan H, Ozdemir N, Yilmaz U, Boyacioglu S. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Dig Dis Sci. 2006 Aug;51(8):1420-5.
125. Kanbay M, Selcuk H, Yilmaz U. Dysphagia caused by cervical
osteophytes: a rare case. J Am Geriatr Soc. 2006 Jul;54(7):1147-8. 126. Kanbay M, Aydogan T, Bozalan R, Isik A, Uz B, Kaya A, Akcay A.
A Rare but serious side effect of Levofloxacin: hypoglycemia in a geriatric patient. Diabetes Care. 2006 Jul;29(7):1716-7.
127. Kaya A, Kanbay M, Bayrak O, Kurtaran H, Ark N, Catal F, Akcay A. Concomitant nephrotic syndrome with antinuclear antibody seropositivity and Hashimoto thyroiditis in a patient with mycosis fungoides. South Med J. 2006 Jun;99(6):631.
128. Kanbay M, Kaya A, Bozalan R, Aydogan T, Uz B, Isik A, Akcay A.
Gabapentin induced edema in a geriatric patient. Clin Neuropharmacol. 2006 May-Jun;29(3):186.
129. Kanbay M, Kanbay A, Boyacioglu S. Helicobacter pylori infection as
a possible risk factor for respiratory system disease: a review of the literature. Respir Med. 2007 Feb;101(2):203-9.
130. Kanbay M, Yildirir A, Ulus T, Bilgi M, Kucuk A, Muderrisoglu H.
Rhesus positivity and low high-density lipoprotein cholesterol: a new link? Asian Cardiovasc Thorac Ann. 2006 Apr;14(2):119-22.
131. Kanbay M, Selcuk H, Gur G, Dagli N, Karakus S, Yilmaz U.
Response to peginterferon treatment in hepatitis C virus-associated splenic lymphoma with villous lymphocytes. Am J Hematol. 2006 Apr;81(4):304-5.
132. Kanbay M, Yildirir A, Akcay A, Colak T, Ozdemir FN, Muderrisoglu
H, Haberal M. Effects of immunosuppressive drugs on serum lipid levels in renal transplant recipients. Transplant Proc. 2006 Mar;38(2):502-5.
133. Selcuk H, Kanbay M, Murat K, Yilmaz U. Liver dysfunction after a gluten-free diet in a patient with celiac disease: a new link? Dig Dis Sci. 2006 Jan;51(1):213-4.
134. Kanbay M, Karakus S, Yilmaz U. Portal vein thrombosis due to
hyperhomocysteinemia caused by vitamin B-12 deficiency. Dig Dis Sci. 2005 Dec;50(12):2362-3.
135. Aydogan T, Kanbay M, Uz B, Kaya A, Isik A, Bozalan R, Erkman M, Akcay A. Fatal hyperphosphatemia secondary to a phosphosoda bowel preparation in a geriatric patient with normal renal function. J Clin Gastroenterol. 2006 Feb;40(2):177.
136. Kanbay M, Gür G, Yücel M, Yilmaz U, Muderrisoglu H.
Helicobacter pylori seroprevalence in patients with coronary artery disease. Dig Dis Sci. 2005 Nov;50(11):2071-4.
137. Guler ZM, Kanbay A, Ciftci B, Kanbay M, Yilmaz A, Agackiran Y, Erdogan Y. Kaposi sarcoma secondary to pulmonary tuberculosis: a rare case. South Med J. 2005 Sep;98(9):933-4.
138. Kanbay M, Akcay A, Huddam B, Usluogullari CA, Arat Z, Ozdemir
FN, Haberal M. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplant Proc. 2005 Sep;37(7):3119-20.
139. Akcay A, Kanbay M, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients. Transplant Proc. 2005 Sep;37(7):3103-5.
140. Yildirim E, Kanbay M, Ozbek O, Coskun M, Boyacioglu S. Isolated idiopathic ovarian vein thrombosis: a rare case. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Jul-Aug;16(4):308-10.
141. Kanbay M, Gur G, Akcay S, Yilmaz U. Helicobacter pylori
seroprevalence in patients with chronic bronchitis. Respir Med. 2005 Oct;99(10):1213-6.
142. Kanbay M, Gür G, Yücel M, Yilmaz U, Boyacioğlu S. Does
eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci. 2005 Jul;50(7):1228-31.
143. Kanbay M, Gür G, Arslan H, Yilmaz U, Boyacioglu S. The
relationship of ABO blood group, age, gender, smoking, and Helicobacter pylori infection. Dig Dis Sci. 2005 Jul;50(7):1214-7. 144. Kanbay M, Sengul A, Güvener N. Trauma induced thyroid storm
complicated by multiple organ failure. Chin Med J (Engl). 2005 Jun 5;118(11):963-5.
145. Kanbay M, Yildirir A, Bozbas H, Ulus T, Bilgi M, Muderrisoglu H,
Akcay A, Ozdemir FN. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. Ren Fail. 2005;27(3):297-303.
146. Kanbay M, Sekuk H, Yilmaz U, Gur G, Boyacioglu S. Acute
pancreatitis associated with combined lisinopril and atorvastatin therapy. Dig Dis. 2005;23(1):92-4.
147. Kanbay M, Gür G, Boyvat F, Taşdelen A, Boyacioğlu S.
Spontaneous aortocaval fistula presenting with acute liver and renal failure: a case report. Turk J Gastroenterol. 2004 Sep;15(3):169-72. 148. Kanbay M, Korkmaz M, Yilmaz U, Gur G, Boyacioglu S. Acute
pancreatitis due to ramipril therapy. Postgrad Med J. 2004 Oct;80(948):617-8.
149. Kanbay M, Gür G, Korkmaz M, Demirci B, Boyacioğlu S. Hepatic
lymphoma metastasis presenting with severe acute liver failure: a rare case. Turk J Gastroenterol. 2004 Jun;15(2):94-6.
150. Akcay A, Kanbay M, Agca E, Sezer S, Ozdemir FN. Neutropenia due to clopidogrel in a patient with end-stage renal disease. Ann Pharmacother. 2004 Sep;38(9):1538-9.
151. Karakuş S, Kanbay M, Köseoğlu HK, Colak T, Haberal M. Causes of anemia in renal transplant recipients. Transplant Proc. 2004 Jan-Feb;36(1):164-5.
152. Akcay A, Kanbay M, Sezer S, Ozdemir FN. Acute renal failure and hepatotoxicity associated with roxithromycin. Ann Pharmacother. 2004 Apr;38(4):721-2.
